Drug profile · INN
chlordiazepoxide
LIBRELEASE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
chlordiazepoxide (LIBRELEASE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN chlordiazepoxide
Brand LIBRELEASE
Route ORAL
Formulation CAPSULE, EXTENDED RELEASE
Frequently asked questions
What is chlordiazepoxide?
chlordiazepoxide (LIBRELEASE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for chlordiazepoxide?
LIBRELEASE is a marketed brand name for chlordiazepoxide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chlordiazepoxide?
chlordiazepoxide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.